Investigators compared the use of linked color imaging vs high-definition white light endoscopy for detection of polyps in patients with Lynch syndrome.
Residual pathologic disease often remains after neoadjuvant chemotherapy and resection in patients with esophageal or GEJ cancers, and these patients have a high risk of recurrence.
Opdivo (nivolumab) is now approved for the treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma.
Opdivo is a programmed death receptor-1 (PD-1)-blocking antibody.
Researchers compared safety and long-term survival of nCRT followed by MIE vs nCT followed by MIE in patients with advanced ESCC.
Researchers aimed to confirm the results of two previous RCTs comparing the effectiveness of radiofrequency ablation vs surveillance in patients with Barrett Oesophagus.
Investigators examined the effectiveness of the PARP inhibitor olaparib in patients with pancreatic cancer with BRCAness.
Researchers presented a case series for the use of endoscopic delivery of stromal vascular fraction obtained by mechanical emulsification of autologous adipose tissue in patients with upper GI tract fistulas.
Investigators explored the mechanism by which solid tumors appear to resist immune checkpoint inhibitor therapies.
Among patients with resected esophageal or gastroesophageal junction cancer who have received neoadjuvant chemoradiotherapy, disease-free survival is significantly longer with nivolumab adjuvant therapy versus placebo.
Researchers assessed the change in the number of endoscopic procedures due to COVID-19 in England and proposed recovery scenarios based on waiting list volumes.
A team of investigators conducted a prospective study to explore the profile of patients with OSAS and LPR at the HEMII-pH and to compare the reflux findings with LPR patients without OSAS.
Investigators evaluated esophagogastric junction distensibility index (EGJ DI) in patients with achalasia at 4 different time points and assessed the association of DI with postoperative outcomes.
The approval was based on data from the KEYNOTE-590 study, which evaluated pembrolizumab plus cisplatin and 5-fluorouracil (5-FU) chemotherapy vs placebo plus cisplatin and 5-FU chemotherapy as first-line treatment.
Researchers assessed the efficacy and cost-effectiveness of proton pump inhibitors vs surgical intervention for acid reflux control.
Investigators analyzed IgE-mediated allergic sensitization patterns in patients with esophageal eosinophilia.
Investigators examined saliva secretion and salivary epidermal growth factor in patients with proton pump inhibitor-resistant severe reflux esophagitis.
Researchers investigated whether endoscopic resection of T1 CRC before secondary surgery adversely affects recurrence risk.
Researchers aimed to evaluate the safety and efficacy of ESD throughout North America.
Researchers aimed to identify disease markers in GERD to describe its progression and severity in patients with persisting symptoms.